Panacea Life Sciences Holdings Inc · OTC:PLSH
Panacea Life Sciences — Exactus — Investor Presentation (June 2020)
25 slides from Panacea Life Sciences's investor presentation, Jun 22, 2020
Slide 1: Exactus
exactus
Slide 2: Cautionary Note Regarding Forward-Looking Statements
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements. You can identify forward-looking statements in this presentation by use of the words “potential,” “expect,” “anticipate,” “target” and similar terminology. Such forward-looking statements incl
Slide 3: Building a Trusted Hemp Derivatives Platform
BUILDING A TRUSTED HEMP DERIVATIVES PLATFORM * Consolidate the supply chain through acquiring farms, processors, and consumer brands * Educate consumers and brands alike to be recognized as the thought leader in the space * Develop hemp-derived specialty ingredients and finished products * Supply US
Slide 4: Federal Legalization of Hemp
FEDERAL LEGALIZATION OF HEMP * 2018 Farm Bill legalized hemp*, shifts hemp production regulation from the Drug Enforcement Agency (DEA) to the United States Department of Agriculture (USDA) at the Federal Level * Significant growth catalyst for industry ¢ Industrial hemp and its byproducts are not i
Slide 5: Hemp CBD Market Forecast
Hemp CBD Market Forecas' The Brightfield Group, September 2018 $20 Estimated Market Size in Billions USD. $18
Slide 6: Experience in Wellness, Health & Farming
EXPERIENCE IN WELLNESS, HEALTH & FARMING EMILIANO ALO! INTERIM CEO Co-founder of Ceed2Med Agro-industrial supply and market development expertise. Co- sponsored research programs for Stevia and Aloe Vera in 2012. ® Gen ~ a ‘ DEREK DU CHESNE ANDREW L. JOHNSON KENNETH E. PUZDER PRESIDENT CHIEF STRATEG
Slide 7: Timeline & Milestones
TIMELINE & MILESTONES J FY 2019 © - Completed first harvest, drying and initiated extraction. - Completed first round of institutional financing. - Hemp market transformation and shift of maturity stage J Q1 2020 - Transformation into customer relationship platform aggregating existing supply chain
Slide 8: Acre Industrial Hemp Farm
200 ACRE INDUSTRIAL HEMP FARM * Two Industrial Hemp Farms in Oregon * Controlling ownership stake (50.1%) * Superior seed genetics * Purchased the rights for 100% of the 2019 harvest * Organic and Proprietary Farming Techniques * All-natural processes and products * Top flower harvest for sale in ea
Slide 9: Traceability from Cultivation to Consumer
TRACEABILITY FROM CULTIVATION TO CONSUMER All-Natural Cultivation © Test & Analysis Drying & Flower GMP Extraction Processing ¢ Test & Analysis ¢ Test & Analysis ‘exactus Building trust with full transparency through entire path to market 7)
Slide 10: Specialty Ingredients
SPECIALTY INGREDIENTS * Exactus is at the forefront of product development for the beverage, food, pets, cosmetics, wellness, and pharmaceutical industries. * Isolates, Distillates, and Water-Soluble * CBD * CBG + CBN * CBC * Isolate, Broad/Full-Spectrum Liquid/Powder Options exactus . aH
Slide 11: Genetics
GENETICS * With over 20 years of experience in agriculture, Exactus is equipped to advise farmers, helping them determine which genetics in the Exactus seed catalog will be superior for each region and farming methodology they are growing in. * USDA compliant feminized hemp seeds * CBD * CBG * High
Slide 12: White Label / Finished Products
& AOE ze RE Z =~ ——— .~ = : WHITE LABEL / FINISHED PRODUCTS * High Scalability * Fully Outsourced Production * Develops Network of Acquisition Targets * High Volumes & High Margins * Formulated Capsules (Softgels, Capsules, Tablets) * Infused Oils (Tinctures) * Topicals / Skin Care * Aromatherapy /
Slide 13: Full Transparency
FULL TRANSPARENCY * Product Description * Product Technical Specifications * Certificate of Analysis of Product * Active Ingredient Technical Specifications * Active Ingredient Third-Party CoA * Strain and Batch Flower Specifications * Strain and Batch Third-Party CoA * Materials Safety Data Sheet (
Slide 14: Industry Evolution
14 INDUSTRY EVOLUTION * CO/KY Programs * Online sales channels + Enactment of 2018 U.S. Farm Bill + Unreliable processes * First differentiated products * Mainstream media and retail * Search for permits * Search for efficiency * Search for mass distribution 4 | ’ * Big Food industrial structure * S
Slide 15: Growth Strategy
GROWTH STRATEGY Developing a Hemp-derived Ecosystem Supported By Best-in-Class Industry Practices GROWTH DRIVERS * Launch Genetics Division * Solidify Co-Packer Manufacturing Agreements * Expand Product Portfolio * Marketing & Brand Developments * Create User Portal ¢ Launch Quick Start White Label
Slide 16: The Plan: Scaling a Hemp-Derived Specialty Ingredients Ecosystem
THE PLAN: SCALING A HEMP-DERIVED SPECIALTY INGREDIENTS ECOSYSTEM * Acquire targeted consumer-facing brands for distribution across various channels * E-commerce (D2C) * Wholesale (B2B) * Big-box retail distribution * Build brand awareness * Specialty ingredients education * Innovative product develo
Slide 17: Distribution Channels
DISTRIBUTION CHANNELS Wholesale distribution Acquire retail distribution channels D2C and B2B digital media campaigns to directly engage with end users and retailers Streamlining E-commerce platform and developing an Amazon portal by our highly experienced team with track record of successful algori
Slide 18: Build a House of Brands Supported by Exactus
Build a House of Brands Supported by Exactus’ Quality Strategy: Develop and acquire brands to service exac tu S under the Exactus ecosystem supported by our —— standards of quality and compliance y,/ ra, * Develop products from our compliant full spectrum of whole plant extract distillates (broad sp
Slide 19: Medical Delivery Systems
MEDICAL DELIVERY SYSTEMS On Nov. 20*, 2019 Exactus signed a Supply & Distribution agreement with Canntab Therapeutics Inc. to produce immediate and extended release tablets. 13 Patents Pending in the United States and Canada covering our proprietary processes and hard pill formulations for: + Extend
Slide 20: Growth Opportunities
GROWTH OPPORTUNITIES Summary Balance Sheet Potential Near-Term Sources of Cash * Sales of hemp-derived specialty ingredients Cash $18,405 | * Genetics sales Current Assets 2,429,235 * White label sales Total Assets 9,799,277 Current Liabilities 1,442,409 Total Liabilities 6,117,431 Targeted Expendit
Slide 21: Investment Summary
INVESTMENT SUMMARY * Controlling ownership in industrial hemp farms assures control and access to high quality hemp supply for commercialization * Full control from seed to market provides product quality control and supports brand strength * Generating revenue in Q1 of 2020 from distribution of a f
Slide 22: At Exactus, we are committed to excellence
At Exactus, we are committed to excellence and it is our goal to standardize the industry with consistency, quality, and transparency. For further information contact: Andrew Johnson, Chief Strategy Officer Email ajo exactus exactus N
Slide 23: Appendix Slides
Appendix Slides
Slide 24: Board of Directors
BOARD OF DIRECTORS JULIAN PITTAM Chairman * Mr. Pittam started his career at Bankers Trust in sales and trading in Hong Kong and Singapore before returning to London to work for Lehman Brothers in 1999 where he was an Investment Banker until 2005. * Head of EMEA for ENSO Financial until 2016 when it
Slide 25: Board of Directors - Continued
BOARD OF DIRECTORS - Continued JUSTIN VILES Independent Director + Justin Viles is the Founder and Director of Innovation at Rokt where he drives innovation across the Rokt product catalog, forming world-class global partnerships. * Prior to Rokt Justin was the Head of Content Acquisition for Austra